Tagged with: Businesses corporate Marie Curie AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Like printing money: charities to benefit from each colour copy National office supplies company Document XL is this month launching its innovative ‘Charity Wrap’ fundraising scheme, making CSR easier than ever for companies by donating money to their chosen charity each time they produce a colour document.Document XL MD Stephen Dobson came up with the idea after reading in a trade magazine that on average, each year, every person in the UK produces over 70,000 copies and prints, mostly in colour and printed on commercial copiers and printers, with most organisations paying anywhere between 4-12 pence to produce a colour document.Stephen thought if his company could capture even a small percentage of these colour pages and donate up to 15% of the copy charge to a company’s chosen charity, thousands of pounds could be raised for good causes in a highly tax efficient way.When Document XL, an authorised Xerox Business Partner, secures an order to supply a company with a business photocopier, printer or multi function machine, they ask the company which charity they’d like to support. Document XL then approaches the charity for their branding, key message and national fundraising telephone number to create the ‘charity wrap’ which can be used on a Xerox copier/printer of any size.The first printers created with the ‘charity wrap’ are for Marie Curie Cancer Care, a charity very close to Stephen’s heart as his mum was treated by Marie Curie nurses during her long battle with cancer. But the wraps can be created for any charity provided they’re able to provide relevant branding and images.Marie Curie Cancer Care Regional Corporate Development Manager Brian Curran said: “We are delighted that Document XL will be supporting us in this way and hope that this initiative raises thousands of pounds for our nurses and Hospices.”Monies are forwarded to a company’s chosen charity each quarter and participating businesses can be seen to be supporting their nominated charity for the lifecycle of the printer which can be included on their CSR Policy, features on their website and any other marketing materials.Most organisations keep a commercial copier or printer for anywhere between 3 to 5 years, therefore each charity is likely to receive funding on a regular basis for many years to come which helps with their planning and budgeting for ongoing projects.Stephen, MD of Document XL, which has offices in Leeds and Rochdale, said: “It’s such a simple idea that I cannot understand why no-one has ever thought of it before. We’re looking to talk to organisations which produce more than 500 colour documents a month, such as schools, universities, national and multi-national companies, really anyone with a conscience who is looking to actively make a difference.”For more information on the “Charity Wrap” fundraising scheme, please visit www.documentxl.com/fundraising and for any enquiries about how to get involved, contact [email protected] or phone 08456 448 600.– ends –Notes to Editor:Images of Stephen Dobson (L) and Brian Curran from Marie Curie (R) are attachedStephen Dobson is available for further commentFor more information please contact:Chocolate PRHelen MacGregor0113 236 [email protected] Howard Lake | 24 November 2011 | News About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. 23 total views, 1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis
“By achieving remission in a second patient using a similar approach, we have shown that the Berlin Patient was not an anomaly, and that it really was the treatment approaches that eliminated HIV in these two people,” said the study’s lead author, Professor Ravindra Gupta (UCL, UCLH and University of Cambridge). Want the best of The Telegraph direct to your email and WhatsApp? Sign up to our free twice-daily Front Page newsletter and new audio briefings. A British man may be the second person to be cured of HIV as doctors said he was in ‘sustained remission’ after being given stem cells from a donor with genetic resistance to the disease.The breakthrough comes 10 years after the first such case, known as ‘The Berlin Patient’. The second person, dubbed ‘The London Patient’ was treated by specialists at at University College London and Imperial College in 2016, and has since shown no sign of the virus.Doctors are hopeful the man is now cured, although say it is too early to make a final call. “While it is too early to say with certainty that our patient is now cured of HIV, and doctors will continue to monitor his condition, the apparent success of stem cell transplantation offers hope in the search for a long-awaited cure for HIV/AIDS,” said Professor Eduardo Olavarria of Imperial College Healthcare NHS Trust and Imperial College London.The therapy works by effectively replacing the blood cells of an infected person with that of someone who is immune to HIV through a genetic mutation which prevents the virus attaching itself to cells. For the treatment he he underwent a haematopoietic stem cell transplant from a donor with two copies of the CCR5 32 allele in 2016 and remained on anti-viral drugs for more than a year after. But in the past 18 months he was taken off the extra drugs and regular testing has confirmed that his viral load is now undetectable.CCR5 is the most commonly used receptor by HIV-1 but people who have two mutated copies of the CCR5 allele are resistant to the HIV-1 virus strain that uses this receptor, as the virus cannot enter host cells.Around 100,000 people in Britain are living with HIV and while the therapy may not be suitable for them all, because of side-effects, the team is now looking into whether it is possible to simply knock out the receptor through gene therapy. The research was published in the journal Nature. “At the moment the only way to treat HIV is with medications that suppress the virus, which people need to take for their entire lives, posing a particular challenge in developing countries.“Finding a way to eliminate the virus entirely is an urgent global priority, but is particularly difficult because the virus integrates into the white blood cells of its host.”The ‘London patient’ who has chosen to remain anonymous was diagnosed with HIV infection in 2003 and on antiretroviral therapy since 2012. Commenting on the breakthrough, Dr Andrew Freedman, Reader in Infectious Diseases and Honorary Consultant Physician, Cardiff University, said:“This an interesting and potentially significant report of a second patient whose HIV infection has gone into remission after receiving a stem cell transplant as part of treatment for a haematological malignancy. “As with the ‘Berlin patient’ who remains free of all traces of the virus more than 10 years later, this patient received stem cells from a donor with a specific genetic mutation rendering them resistant to HIV.“As the authors caution, it is still too early to be certain that this second patient has been cured of HIV. Much longer follow-up will be needed to ensure the virus does not re-emerge at a later stage.” However gene therapy in adults would not be as controversial, as it would not interfere with the germ line, and be passed to future offspring. “Continuing our research, we need to understand if we could knock out this receptor in people with HIV, which may be possible with gene therapy,” added Professor Gupta.The research was partly funded by Wellcome, the Medical Research Council, the Foundation for AIDS Research, and National Institute for Health Research (NIHR) Biomedical Research Centres at University College London Hospitals, Oxford and Cambridge. Timothy Ray Brown – the ‘Berlin Patient’Credit:AP Photo/Manuel Valdes In a recent controversial case in China, a rogue doctor genetically engineered the embryos of two babies to insert the protective gene so they would not contract HIV from their father, the first time a baby has been born with a genetic modification, which sparked worldwide condemnation.